Russell Frank Company’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $6.2M | Buy |
1,953
+1,450
| +288% | +$4.6M | 0.01% | 1212 |
|
|
2015
Q4 | $2.6M | Sell |
503
-76
| -13% | -$393K | ﹤0.01% | 1681 |
|
|
2015
Q3 | $1.84M | Buy |
579
+18
| +3% | +$57.3K | ﹤0.01% | 1897 |
|
|
2015
Q2 | $2.24M | Buy |
561
+135
| +32% | +$540K | ﹤0.01% | 1903 |
|
|
2015
Q1 | $1.7M | Sell |
426
-59
| -12% | -$235K | ﹤0.01% | 1873 |
|
|
2014
Q4 | $2.37M | Sell |
485
-1,510
| -76% | -$7.36M | ﹤0.01% | 1686 |
|
|
2014
Q3 | $8.11M | Buy |
1,995
+661
| +50% | +$2.69M | 0.01% | 1003 |
|
|
2014
Q2 | $4.82M | Buy |
1,334
+1,030
| +339% | +$3.72M | 0.01% | 1340 |
|
|
2014
Q1 | $1.27M | Buy |
+304
| New | +$1.27M | ﹤0.01% | 1981 |
|
|
2013
Q4 | – | Sell |
-180
| Closed | -$742K | – | 3135 |
|
|
2013
Q3 | $742K | Sell |
180
-19
| -10% | -$78.3K | ﹤0.01% | 2322 |
|
|
2013
Q2 | $789K | Buy |
+199
| New | +$789K | ﹤0.01% | 2163 |
|